MedPath

Vaginal Cleansing Before Cesarean Delivery to Reduce Infection

Not Applicable
Completed
Conditions
Complications; Cesarean Section
Registration Number
NCT02495753
Lead Sponsor
Washington University School of Medicine
Brief Summary

The purpose of this study is to test the hypothesis that vaginal cleansing with povidone-iodine solution immediately prior to cesarean delivery reduces postcesarean infectious morbidity.

Detailed Description

Cesarean delivery is the most common surgical procedure performed on women in the US; nearly 1.3 million are performed each year. Postoperative infectious morbidity is the most common complication of cesarean delivery. Post-cesarean infectious morbidity is often the result of indigenous vaginal flora that ascend into the uterus at the time of surgery. Thus, reducing vaginal microbial load may reduce post-cesarean infection. However, results from studies assessing the role of vaginal cleansing prior to cesarean have been mixed.

The investigators will perform a randomized controlled clinical trial to test the hypothesis that vaginal cleansing with povidone-iodine solution immediately prior to cesarean delivery reduces postcesarean infectious morbidity.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
608
Inclusion Criteria
  • Women undergoing cesarean delivery after labor at Barnes-Jewish Hospital.
Exclusion Criteria
  • Inability to obtain consent
  • known or suspected allergy to iodine or shellfish
  • women with active herpes simplex virus infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Composite Postoperative Infectious Morbidity30 days postoperatively

Maternal fever, endometritis, intrabdominal infection or abscess, wound complication within 30 days of delivery or wound infection.

Secondary Outcome Measures
NameTimeMethod
Adverse Reaction to Vaginal Cleansing30 days postoperatively

Hypersensitivity Reaction or more severe allergic reaction

Number of readmissions to hospital for infectious morbidity.30 days postoperatively

Number of times patient is readdmitted for any infectious morbidity.

Number of outpatient visits for infectious morbidiy.30 days postoperatively.

Number of outpatient or emergency room visits related to infectious morbidity.

Treatment for neonatal Sepsis30 days postoperatively

Any antibioitics given for neonate with suspected sepsis.

Length of Hospital Stay30 days postoperatively

Days in hospital

Trial Locations

Locations (1)

Barnes Jewish Hospital

🇺🇸

Saint Louis, Missouri, United States

Barnes Jewish Hospital
🇺🇸Saint Louis, Missouri, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.